AJ302
/ AnnJi Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
December 30, 2025
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJ302-IM in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=57 | Completed | Sponsor: AnnJi Pharmaceutical Co., Ltd. | Recruiting ➔ Completed
Trial completion
October 03, 2024
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJ302-IM in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=56 | Recruiting | Sponsor: AnnJi Pharmaceutical Co., Ltd.
New P1 trial
1 to 2
Of
2
Go to page
1